[Idiopathic sudden sensorineural hearing loss. What's the appropriate management?]

Tunis Med. 2007 Oct;85(10):839-42.
[Article in French]

Abstract

Background: Sudden sensorineural hearing loss remains a challenge in otology. Controverses affect mainly etiopathogeny and treatment.

Aim: To evaluate our experience in the diagnosis and the treatment of sudden hearing loss

Methods: We report a retrospective study, including 30 patients presenting a Sudden sensorineural hearing loss. All patients were hospitalized for treatment. The audiometry evaluated the hearing deafness before and after treatment.

Results: The average age was of 48 years. In all the cases no etiology has been found. All The patients were hospitalized and corticotherapy was administrated in all cases. It was associated to hyperbare oxygenotherapy in 7 patients. Recovery was observed mainly in patients with moderate (71.4%) and severe hearing deficiency (69.2%).

Conclusion: Corticosteroids are the less controversed treatment of sudden sensorineural hearing loss.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Inflammatory Agents / therapeutic use
  • Aspirin / therapeutic use
  • Audiometry, Pure-Tone
  • Child
  • Female
  • Glucocorticoids / therapeutic use
  • Hearing / physiology
  • Hearing Loss, Sudden / diagnosis
  • Hearing Loss, Sudden / therapy*
  • Hospitalization
  • Humans
  • Hyperbaric Oxygenation
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Nafronyl / therapeutic use
  • Pentoxifylline / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use
  • Recovery of Function / physiology
  • Retrospective Studies
  • Treatment Outcome
  • Vasodilator Agents / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • Glucocorticoids
  • Platelet Aggregation Inhibitors
  • Vasodilator Agents
  • Nafronyl
  • Aspirin
  • Pentoxifylline
  • Methylprednisolone